Anti Proteinase 3 Ab

Sample type: Serum
Optimal result: 0 – 20 CU

Elevated levels of Anti-Proteinase 3 antibodies, or PR3-ANCA, usually indicate a specific type of autoimmune disorder called Granulomatosis with Polyangiitis (GPA). In this condition, the body's immune system mistakenly attacks its own cells, particularly affecting blood vessels and organs like the kidneys and lungs. When these antibody levels are high, it often means that the disease is active and may be causing inflammation and damage in these areas. Doctors use this information to diagnose GPA, understand how severe the disease might be, and decide on the best treatment approach. It's important to know that while high levels of these antibodies are closely associated with GPA, they can sometimes be seen in other conditions too.

Anti-Proteinase 3 antibodies (PR3-ANCA) are key in diagnosing Granulomatosis with Polyangiitis (GPA), an autoimmune disease where the immune system attacks blood vessels, mainly affecting the respiratory system and kidneys. Proteinase 3, an enzyme in neutrophils, is targeted by these antibodies, leading to vessel inflammation and damage. High levels of anti-PR3 antibodies indicate active GPA, aiding in its management and treatment decisions. This understanding is vital for developing targeted therapies to control the disease.

Anti-Proteinase 3 antibodies (PR3-ANCA) are a significant biomarker in the Neutrophil Cytoplasmic Antibodies (ANCA) panel, primarily used in the diagnosis and management of certain autoimmune vasculitides, notably Granulomatosis with Polyangiitis (GPA).

What is Granulomatosis with Polyangiitis (GPA)?

Granulomatosis with Polyangiitis (GPA), formerly known as Wegener's Granulomatosis, is a rare autoimmune disease where the body's immune system mistakenly attacks its own blood vessels, causing inflammation. This inflammation primarily affects the respiratory system (like the sinuses, nose, trachea) and the kidneys, but it can involve other organs too. Symptoms can vary but often include nasal congestion, nosebleeds, cough, and kidney problems. If not treated, GPA can lead to organ damage. The exact cause of GPA is unknown, but treatment typically involves medications to suppress the immune system and reduce inflammation, helping to manage symptoms and prevent further damage to the organs.

What is Proteinase 3 and what are anti-PR3 antibodies?

Proteinase 3 is a serine protease enzyme predominantly located in the azurophilic granules of neutrophils and is involved in the degradation of extracellular matrix components, playing a key role in the innate immune response. The presence of anti-PR3 antibodies indicates an aberrant autoimmune response, wherein the immune system erroneously targets and attacks PR3, leading to inflammation and damage in blood vessels.

These antibodies are typically of the IgG class and are detected using techniques such as indirect immunofluorescence (IIF) and enzyme-linked immunosorbent assay (ELISA). In IIF, they usually show a cytoplasmic staining pattern (c-ANCA), reflecting their target location within neutrophils. The ELISA method provides a more specific and quantitative assessment of anti-PR3 antibodies.

Clinically, the detection of anti-PR3 antibodies is highly indicative of GPA, formerly known as Wegener's granulomatosis. Patients with GPA often present with high titers of these antibodies, and their levels have been correlated with disease activity, severity, and potential relapse. The presence of anti-PR3 antibodies is less common in other forms of vasculitis and can occasionally be observed in other autoimmune disorders, albeit less specifically.

Pathophysiologically, anti-PR3 antibodies are believed to contribute to the development of vasculitis by activating neutrophils, which in turn adhere to endothelial cells, release cytotoxic substances, and trigger a cascade of inflammatory responses leading to vessel wall damage. This process results in the characteristic features of vasculitis, such as vessel inflammation, necrosis, and granuloma formation.

Understanding the role and dynamics of anti-PR3 antibodies in GPA has not only been crucial for diagnostic purposes but also has significant therapeutic implications. It guides the use of immunosuppressive therapy and other targeted treatments to manage the autoimmune response and prevent disease progression. Continuous research and advancements in the understanding of these antibodies and their mechanisms of action are central to improving the diagnosis, monitoring, and treatment of autoimmune vasculitides.

Anti Proteinase 3 Ab
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Anti Proteinase 3 Ab — 10,000+ markers explained
One Anti Proteinase 3 Ab result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro